Conferences  >  Medicine & Healthcare  >  Oncology

MCI Germany GmbH

On behalf of the European Association for Haematopathology (EA4HP) and the Society for Hematopathology (SH), it is with greatest pleasure that I invite you to attend the 22nd Meeting of the EA4HP in Dubrovnik, Croatia. The meeting will take place at the Hotel Valamar Lacroma Conference Centre from 21th to 26th September, 2024. This venue is one of the largest conference facilities in the region, located in a green oasis of the Babin kuk peninsula, 5 km from Dubrovnik's Old Town and approximately 20 km from the airport. For the participants unable to join us in Croatia, there will be an option to register for the hybrid event.

With a diverse scientific program, the meeting covers a wide range of topics, including Thymus Pathology, hot topics in hematopathology, reactive and therapy-induced changes, myeloid neoplasms, novel mechanisms in lymphomagenesis, and the boundaries between neoplastic and reactive lymphoproliferations. It offers a unique opportunity to explore the current trends, advancements, and challenges in the field.

For more information and to register, please visit the official conference website: EA4HP 2024 Conference. We look forward to welcoming you to Dubrovnik for an exceptional and inspiring event.

Email: ea4hp-sh@wearemci.com

Haematopathology, Lymphoma, Bone Marrow, B-cell lymphoma, Hodgkin lymphoma, myeloid neoplasms, Hematology, Pathology

Thomas Jefferson University

The early detection of lung cancer involves a complex care pathway and interdisciplinary approach. The 5th Annual Lung Cancer Screening Summit offers physicians and nurses a comprehensive lung cancer update. Topics for the summit include keynote lectures on lung cancer screening and public health and health disparities specifically designed to meet the educational needs of our audience. Attendees will hear from lung cancer faculty experts on lung cancer risk, lung cancer screening, diagnosis, and implementation of lung cancer screening programs.

Office of CPD;     Phone: [2159556992];     Email: jeffersoncpd@jefferson.edu

Lung Cancer

This CME-accredited activity is a two-day conference aimed at improving the knowledge and competence of academic and community oncology providers on the biomarker-guided treatment of cancer, and design and conduct of clinical trials in the era of novel therapies.

Email: taylor.s@binayfoundation.org

oncology, cme conference, immunotherapy, novel therapies, cancer therapy, immunooncology, cme credit, continuing medical education, cancer, cancer care, oncology conference, cancer conference

Continuing Medical Education (CME),    Regulation in Medicine and Pharmacology

Binaytara Foundation

The 2023 Midwest Precision Oncology Symposium, is an accredited continuing education activity designed to improve the care of cancer patients by educating cancer care providers about precision oncology. This oncology conference features leading experts in the field of precision oncology who will provide a comprehensive overview of the implications of actionable molecular alterations across common malignancies. Designed to facilitate learning, improve knowledge retention, and inspire participants to implement the newly acquired knowledge into their clinical practice. Through didactic lectures, case-based discussions, and interactive questions and answer sessions, participants will be able to ask relevant questions, clarify concerns, and network with expert faculties.

Event Planner;     Phone: [4255575953];     Email: support@binayfoundation.org

precision-oncology, oncology, molecular-targeted-treatment, molecular-targeted-therapies, CME, ACCME

Deutsche Gesellschaft für Neuroradiologie e.V.

Kongressmotto Kommunikation und Vernetzung für eine starke Neuroradiologie

Die Deutsche Gesellschaft für Neuroradiologie (DGNR) und die Österreichische Gesellschaft für Neuroradiologie (ÖGNR) laden zur gemeinsamen Jahrestagung nach Kassel ein.

Deutsche Gesellschaft für Neuroradiologie e.V.;     Email: dgnr@neuroradiologie.de

Neuroradiologie, Radiologie, Onkologie, Neuroonkologie, MRT und CT

ESMO - European Society for Medical Oncology

MAP is the leading congress in precision oncology, designed to provide the latest breaking data in the field of molecular profiling and personalised medicine. The focus of the event is to create a bridge between basic scientists, or people working on new technologies, and medical doctors and healthcare providers. Our globally recognised experts in clinical and precision oncology will welcome delegates for three days of discussions on the latest discoveries in precision medicine, cancer-stromal interactions, clonal evolution, metastatic dissemination and drug response and resistance.

The MAP Congress is the result of a solid partnership among Cancer Research UK (CRUK), the European Society for Medical Oncology (ESMO) and Unicancer, all committed to offering the best care to people with cancer worldwide, through oncology education and research.

MAP Congress Team;     Phone: [+41919731947];     Email: map@esmo.org

oncology, personalised medicine, precision medicine, translational research, molecular characterisation, clonal evolution, cancer profiling, metastatic dissemination, biomarkers, targeted therapeutics

Translational Medicine, Clinical Trials,    Pharmacogenomics, Personalized Medicine

Bio Ascend LLC

The International Workshop on Chronic Lymphocytic Leukemia (iwCLL) is a biennial meeting focused solely on advancing the understanding and treatment of chronic lymphocytic leukemia (CLL) and related lymphoproliferative disorders. Founded in 1979, iwCLL is now the largest international meeting dedicated to advancing state-of-the-art and emerging concepts—from laboratory-based research to the clinic—in the pathobiology and treatment of these blood cancers. The biennial meeting is intended to provide a forum that promotes the exchange of information and encourages collaboration among international leaders and scientists interested in CLL and lymphoproliferative disorders in one location for 4 days every other year.

Chronic lymphocytic Leukemia, ( CLL)

Continuing Medical Education (CME),    Hematology

Binaytara Foundation

The 2023 Precision Oncology Summit: Personalizing Treatment to Improve Patient Outcomes is an oncology conference featuring leading experts in the field of precision oncology who will provide a comprehensive overview of the implications of actionable molecular alterations across common malignancies.

Expert faculty will discuss and analyze the latest scientific findings and practice-changing advances in precision oncology, including the key abstracts relevant to precision oncology presented at the 2023 ASCO Annual Meeting in June 2023.

Event Planner;     Phone: [4255575953];     Email: support@binayfoundation.org

oncology, CME-credits

European Molecular Biology Laboratory | EMBL

Liquid biopsies have the advantage of being largely non-invasive and providing a vast amount of information for the detection and monitoring of diseases such as cancer. This course will provide an overview in the several techniques to detect and analyse circulating tumour cells (CTCs), cell free tumor DNA (ctDNA), miRNA in liquid biopsies, cell free tumour RNA (ctRNA) and proteins. Participants will be introduced to all aspects ranging from proper sampling through error free sequencing to data analysis. Additional lectures will cover extracellular vesicles and clinical aspects using liquid biopsies, especially in the field of cancer diagnostics. 

Biology,    Exhibitions and Trade Shows in Chemistry, Laboratory Technology

The European Association for Cancer Research (EACR)

The EACR Goodbye Flat Biology conference returns in-person to focus on the next generation of cancer models and emerging topics in the areas of cell architecture, mechanobiology, the immune microenvironment, intravital imaging and high-content analysis for cancer therapeutics.

Binaytara Foundation

This program, the Santa Fe Precision Oncology Symposium, is an accredited continuing education activity designed to improve the care of cancer patients by educating cancer care providers about precision oncology.

Email: taylor.s@binayfoundation.org

precision oncology, oncology, cme, cme conference, oncology conference, binaytara foundation, cancer care, cancer, cancer disparities, nonprofit organization, symposium

Binaytara Foundation

This CME-accredited activity, “2023 Global Oncology Summit: Focus on Sustainability”, is a half-day hybrid conference featuring didactics, panel discussions, and abstract presentations. The expert faculty will provide a comprehensive overview of the sustainable approach to establishing global oncology programs in low and middle-income countries (LMIC). They will discuss the challenges and evidence-based solutions to tackle these issues.

Email: taylor.s@binayfoundation.org

oncology, sustainability, cme conference, binaytara foundation, cancer, global oncology,

Binaytara Foundation

This CME-accredited activity, PARP Inhibitors in Prostate Cancer – Recent Updates and Implications for Clinical Practice, is designed to provide expert interpretation of new and emerging data on the treatment of prostate cancer with PARP inhibitors (PARPi) as a single agent or potential new combination treatments, the maintenance setting.

Phone: [4256160572];     Email: taylor.s@binayfoundation.org

parp, parp inhibitors, prostate cancer, binaytara foundation, dr. binay shah, continuing medical education, cme, cme conference

FomF GmbH - Forum für medizinische Fortbildung

Zertifizierte Fortbildung für ÄrztInnen der Hämatologie und Onkologie vor Ort in Köln & via Livestream, 03. - 04.11.23. Updates & die neuesten Leitlinien. 16 CME-Punkte wurden bei der zuständigen Ärztekammer angefragt. Jetzt informieren & buchen!

Phone: [+49 (0) 6192 47072 00];     Email: info@fomf.de

Binaytara Foundation

This program, the Salt Lake City Precision Oncology Symposium, is an accredited continuing education activity designed to improve the care of cancer patients by educating cancer care providers about precision oncology.

Email: taylor.s@binayfoundation.org

oncology, cme conference, cme, oncology conference, precision oncology, binaytara foundation

Cleveland Clinic

The 24th Annual Brain Tumor Update and the 13th Annual Symposium on Brain Metastases and Spine Tumors is co-provided by Cleveland Clinic and Keck School of Medicine of the University of Southern California. This advanced multidisciplinary meeting is led by expert faculty from Cleveland Clinic and USC, with additional internationally recognized guest faculty. This symposium is designed to improve competence to assess and treat patients with brain tumors and tumors of the spine, especially as it relates to comparing treatments for brain metastases and spine tumors, evaluating new technologies, treating meningiomas, and assessing and treating gliomas, with the overall goal of improving outcomes in these patient populations.

Email: eatonl3@ccf.org

neurosurgery, neurology, oncology, radio surgery, brain tumors, brain metastases

Neurology,    Surgery

Fraunhofer-Institut, Universitätskrebszentrum des Universitätsklinikums Leipzig, event lab. GmbH

The Leipzig Immune ONcology (LION) Conference will bring together clinicians, scientists and industry to discuss latest developments and highlights on special issues of immune oncology. The annual meeting is organized by the Fraunhofer Institute for Cell Therapy and Immunology and the University Cancer Center of the University Hospital Leipzig.

event lab. GmbH;     Phone: [0341 308884 – 89];     Email: tbaehr@eventlab.org

Oncology, Onkologie, Zellforschung, Immuntheraphie, cancer

Immunology and Allergic Diseases,    Stem-cell Research & Therapy

The 2023 Meeting in Mainz will bring together renowned specialists in the field of surgical and medical oncology, pathology, endoscopy, diagnostic and interventional radiology as well as radiotherapy. Experts from all around the world will meet in Mainz for an intensive three-day discussion on diverse aspects of liver tumors.

The 2023 program attempts to cover the most recent highlights and relevant issues on the diagnosis, management, treatment, and research of primary and secondary malignancies of the liver. This will include new surgical techniques as laparoscopic and robotic hepatobiliary surgery, new aspects in the multimodal treatment of hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and liver metastases, biological agents, immunotherapy, radiologic-interventional approaches, but also aspects as pre-habilitation and many more.

Email: ewalt@wikonect.de

Radiology, Nuclear Medicine and Radiation Therapy,    Hepatology

FomF GmbH - Forum für medizinische Fortbildung

Zertifizierte Fortbildung für ÄrztInnen der Hämatologie und Onkologie vor Ort in Stuttgart & via Livestream, 10.-11.11.23. Updates & die neuesten Leitlinien. 16 CME-Punkte wurden bei der zuständigen Ärztekammer angefragt. Jetzt informieren & buchen!

Phone: [+49 (0) 6192 47072 00];     Email: info@fomf.de

Continuing Medical Education (CME),    Hematology

Oxford Global

Hear from and meet with the leading figures in precision oncology to explore how companies are innovating in precision medicine, digital pathology and molecular testing to accelerate timelines and reduce risk in drug development, with in-depth consideration of the latest multiplexed and cytometry tools impacting biomarker research & validation.

Oxford Global;     Email: c.ashford@oxfordglobal.co.uk

biomarkers, precision oncology, precision medicine, digital pathology, molecular testing

The European Association for Cancer Research (EACR)

This conference will focus on the most recent studies that have uncovered novel molecular pathways involved in response anticancer therapy. A panel of speakers involved in cutting-edge studies on the biological and cellular bases for therapeutic response in cancer will share their vision on how these disruptive discoveries could be exploited to rethink cancer therapies to ultimately improve therapeutics.

Phone: [N/A];     Email: hannah.barrs@eacr.org

cellular basis, cancer response, patient response, cell line, chemotherapy, hormone therapy, in vivo models, in vivo validated cellular effects, mechanism-based combinations, novel molecular pathways, anticancer therapy, biological basis for therapeutic response, mitochondrial homeostasis, chemotherapy agents, tumor microenvironment, experimental therapeutics, drug repositioning, cancer research, oncology

Impact Conferences

Impact Conferences cordially invites all participants from around the world to attend 3rd International Conference on Cancer Research and Therapy 2023,which will take place on November 16-17, 2023. We believe our decision will allow for broad participation.

Email: ameyakiyaoncology@gmail.com

Oncology, Cancer, Breast Cancer

Bioevents Ltd

It is with great pleasure that we invite you to join us in person at The 4th European Congress on Controversies in Leukemia (Euroleuk2023) which will take place 20-21 November 2023 in Brussels, Belgium. The diagnosis and treatment of acute and chronic leukemia are changing dramatically. In recent years, numerous new drugs have entered the market, changing the prognosis of leukemia patients. In this context, a continuous exchange among peers, together with the opportunity to hear the most important news from the voices of Europe’s leading key opinion leaders, is essential to ensure the best level of care for leukemia patients. The all-new format will feature debate-style presentations on hot topics in acute and chronic leukemia, with speakers presenting contrasting views to stimulate interactive discussion with faculty and attendees. Euroleuk2023 will continue to provide clinicians and biologists with the latest recommendations for patient care, as well as insights into controversies and new therapeutic perspectives in the field.

Phone: [00442030514032];     Email: ilana@bioevents-congress.com

acute myeloid leukemia, AML, acute lymphoblastic leukemia, ALL, chronic lymphocytic leukemia (CLL), stem cell transplantation, leukemia, leukaemia, treatment, immunotherapy, clincial, biology, diagnosis, ELN2022, WHO2022,

Continuing Medical Education (CME),    Stem-cell Research & Therapy

FomF GmbH - Forum für medizinische Fortbildung

Zertifizierte Fortbildung für ÄrztInnen der Hämatologie und Onkologie vor Ort in Berlin & via Livestream, 24.-25.11.23. Updates & die neuesten Leitlinien. 16 CME-Punkte wurden bei der zuständigen Ärztekammer angefragt. Jetzt informieren & buchen!

Phone: [+49 (0) 6192 47072 00];     Email: info@fomf.de

Continuing Medical Education (CME),    Hematology

ESMO - European Society for Medical Oncology

The ESMO Asia Congress 2023 will welcome you in Singapore from 1 to 3 December, to present and discuss the latest scientific and clinical advances across the entire field of oncology, of relevance at a global level, and for the Asia-Pacific region. The outstanding scientific programme will cover the latest advances on the most prevalent cancer types in the region, offering high quality multidisciplinary educational sessions and special sessions in collaboration with illustrious international and Asia-Pacific oncology associations.

As usual, there will be a special focus on the Pan-Asian Guidelines Adaptation (PAGA) Lectures, conceived to share best practice standards of care for cancer patients and providing a framework for the structured interaction of key opinion leaders in oncology from Asia and Europe.

We hope you will be part of that journey by attending ESMO Asia 2023, where we will unite the Asian and global oncology community and share unforgettable moments!

Email: asiacongress@esmo.org

Breast cancer, CNS, Developmental and precision medicine, gastrointestinal tumours, genitourinary tumours, gynaecological malignancies, head and neck cancer, investigational immunotherapy, melanoma, public policy, sarcoma, rare tumours, thoracic cancer, oncology

Pharmacogenomics, Personalized Medicine,    Translational Medicine, Clinical Trials

The European Association for Cancer Research (EACR) and AstraZeneca

Epigenetic control is essential for development and differentiation, and this control mechanism is very frequently deregulated in cancer. Several small molecule inhibitors have been developed in recent years that have either been approved for clinical use or are in preclinical and clinical trials. This conference will focus on basic and clinical aspects of targeting a broad panel of epigenetic proteins in cancer, either as monotherapies, or as combination therapies, including the use of immune checkpoint inhibitors to increase drug sensitivity and overcome chemoresistance.

Phone: [N/A];     Email: hannah.barrs@eacr.org

epigenetics, molecule inhibitors, epigenetic proteins in cancer, monotherapies, combination therapies, immune checkpoint inhibitors, drug discovery, drug sensitivity, chemoresistance, genetically targeted cancer therapy, novel epigenetic targets, drug resistance, clinical cancer trials, cancer research, oncology

The PAMM EORTC meeting is a unique blend of translational and clinical research in oncology – covering the latest innovations in targeted therapies and immunotherapies, experimental therapeutics, precision medicine and cutting-edge oncology. Invited speakers include opinion leaders in their respective fields, either as clinical investigators or researchers – plus a selection of abstracts presented by young scientists and private symposia sponsored by pharmaceutical partners covering the latest advances in cancer treatment.

Fusion Conferences

The 6th DNA Repair/Replication Structures & Cancer conference on 14-18 February 2024 will focus on molecular structural and mechanistic insights into dynamic complexes acting in DNA repair, replication, and inflammation and their intersections relevant to advanced cancer therapies. This fundamental information will be pivotal for pioneering research on DNA damage responses as well as for the accurate interpretation of cancer clinical data, design of clinical trials, prognosis, etiology and improving the currently low success rate for oncology drug clinical trials. Informative talks and poster sessions along with vibrant discussions will foster productive interactions, collaborations, and insights. In this conference and this area of science basic research is empowering medical advances and clinical data are unveiling basic relationships in ways that are completely changing how research and translation is being done.

Molecular Biology,    Genomics and Bioinformatics

Deutsche Krebsgesellschaft e. V. und Stiftung Deutsche Krebshilfe

Motto: Fortschritt gemeinsam gestalten

Der Kongress umfasst kompakte und intensive Bestandsaufnahme der aktuellen Forschungsergebnisse und Situation in der Onkologie in Deutschland.

Beleuchtet werden aktuelle und künftige medizinische Entwicklungen und neue Therapien für alle Tumorentitäten. Zudem Schwerpunkte und Fragen zur Gesundheitspolitik.

Kongress- und Kulturmanagement GmbH

European Association for Cancer Research (EACR) & American Association for Cancer Research (AACR), with support from the Irish Association for Cancer Research (IACR)

The EACR and AACR are proud to announce the 2024 edition of their joint Basic and Translational Research Conference, organised in conjunction with the IACR. The forum will highlight the latest cutting-edge advances in the understanding of the genomics, epigenetics, and molecular pathways involved in the development of pre-cancerous and cancerous lesions, and in cancer response to therapy. The scientific programme blends basic and translational research from preclinical models to patients. Topics include immunotherapy, cell-based therapies, novel/undruggable targets, drug combinations and resistance, the precancer genome, liquid biopsies, preclinical models, the tumour microenvironment, and epigenetics. The target audience is basic and translational scientists, experienced investigators and trainees at all levels with an interest in cancer development and treatment, and clinicians involved in the development of novel therapeutic approaches to treatment.

Event organiser: New Way Management;     Email: eacr@newway-management.com

NK cell immunity, CAR T cells, solid tumours, PML nuclear bodies, AML response to therapies, synergistic cancer drug combinations, immune contexture, immunoscore, carcinogenesis, Clonal Hematopoiesis (prevention of hematologic malignancies), Fanconi anemia, stem cell attrition, genomic instability, neoadjuvant immune checkpoint blockade, cancer liquid biopsies, MYC inhibitor, preclinical models for translational research, stromal heterogeneity and spatial distribution, cell plasticity, disease mechanisms in cancer, Polycomb Epigenetic Regulators, cancer research, oncology

FomF GmbH - Forum für medizinische Fortbildung

Zertifizierte Fortbildung für ÄrztInnen der Hämatologie und Onkologie vor Ort in Frankfurt & via Livestream,03.-04.05.2024. Updates & die neuesten Leitlinien. 16 CME-Punkte wurden bei der zuständigen Ärztekammer angefragt. Jetzt informieren & buchen!

Phone: [+49 (0) 6192 47072 00];     Email: info@fomf.de

Continuing Medical Education (CME),    Hematology

The European Association for Cancer Research (EACR)

This meeting will cover the latest exciting breakthroughs on multiple aspects of the tumour microenvironment, including the intricate interactions of cancer cells with the immune system and with specific stromal cells in multiple organs. We will also highlight novel insights into tumour-host interactions including changes in metabolism, the nervous system and response to therapy.

Join us to hear from world experts who are at the forefront of the tumour microenvironment field, sharing their latest discoveries and insights about this cutting-edge research and its implications for novel cancer therapies. Featured topics include the role of inflammation and immunity in tumour progression and metastasis, organ-specific stromal cells that support tumour progression, metabolic changes in the tumour microenvironment, tumour-host interactions in response to therapy, cancer interactions with the nervous system, and dormancy and metastasis.

The target audience for this conference is: scientists, postdocs, and graduate students interested in multiple aspects of cancer biology, immunology, and therapeutics; industry scientists interested in translational research and novel therapeutic approaches; and journal editors interested in cutting-edge cancer biology.

Conference Officer: Hannah Baars;     Email: hannah.barrs@eacr.org

tumour ecosystem, carcinogenesis, metastasis, tumour therapy response, novel therapeutics, reciprocal cancer-stroma interactions, tumour progression, organ-specific stromal cells, tumour-host interactions, nervous system interactions, tumour dormancy, metastasis progression, ECM remodelling, therapy resistance, immune cell heterogeneity, stromal plasticity, immune plasticity, fibroblast interactions, treatment resistance, cancer research, oncology

The European Association for Cancer Research

This meeting will cover the latest exciting breakthroughs on multiple aspects of the tumour microenvironment, including the intricate interactions of cancer cells with the immune system and with specific stromal cells in multiple organs. We will also highlight novel insights into tumour-host interactions including changes in metabolism, the nervous system and response to therapy. Join us to hear from world experts who are at the forefront of the tumour microenvironment field, sharing their latest discoveries and insights about this cutting-edge research and its implications for novel cancer therapies. Featured topics include the role of inflammation and immunity in tumour progression and metastasis, organ-specific stromal cells that support tumour progression, metabolic changes in the tumour microenvironment, tumour-host interactions in response to therapy, cancer interactions with the nervous system, and dormancy and metastasis.

Email: hannah.barrs@eacr.org

tumour ecosystem, carcinogenesis, metastasis, tumour therapy response, novel therapeutics, reciprocal cancer-stroma interactions, tumour progression, organ-specific stromal cells, tumour-host interactions, nervous system interactions, tumour dormancy, metastasis progression, ECM remodelling, therapy resistance, immune cell heterogeneity, stromal plasticity, immune plasticity, fibroblast interactions, treatment resistance, cancer research, oncology

The TWC is an international conference that brings together leading experts in the field from around the world. Our goal is to provide a platform for researchers, students, clinicians, and industry professionals to share their knowledge, learn and discuss the latest advancements in this exciting field.

Theranostic, Radiomolecular Precision Medicine, RPM, Radioisotopes, Prostate Cancer, Radiotherapy, Tumor Microenvironment, NET, Radioisotopes, Congress

Radiology, Nuclear Medicine and Radiation Therapy,    Pharmacology and Drug Development

Österreichische Gesellschaft für Hämatologie & Medizinische Onkologie

GEMEINSAM stärker – Stronger together ist das Thema unserer Frühjahrstagung 2024. Nicht nur die letzten Jahre haben unser Denken durch die COVID-Pandemie verändert. Auch schon davor hat sich immer klarer gezeigt, dass wir GEMEINSAM stärker sind. GEMEINSAM, was die Erforschung, das Behandeln und schließlich auch in immer mehr Fällen das Besiegen der Erkrankungbetrifft. GEMEINSAM ist hier ebenso interdisziplinär zu verstehen, und zwar über alle Berufsgruppen hinweg: dazu zählt die Pflege genauso wie die klinische Psychologie, die Studienkoordinator*innen, Grundlagenforschung und klinische Forschung, aber natürlich auch unsere Patient*innen.

Sekretariat der OeGHO;     Email: office@oegho.at

Frühjahrstagung, Hämatologie, Onkologie, OeGHO, AHOP

The European Association for Cancer Research

This revamped iteration of our renowned Cancer Genomics series will cover the latest exciting developments in the fields of genomics and bioinformatics including machine learning and AI, single-cell and spatial analysis of cancers, cell plasticity, cancer immunity genomics, data integration and convergence, epigenetics, and genomic instability. Featuring an exceptional international faculty, extensive networking opportunities and a limited number of in-person participants, this conference will provide both the possibility and intimate setting for top quality scientific interaction. We look forward to welcoming you to the Weizmann Institute of Science for this exciting meeting!

Conference Officer: Chris Iliffe;     Email: christopher.iliffe@eacr.org

multiomics, computational biology, machine learning, artificial intelligence, single-cell analysis, spatial analysis, cell plasticity, cancer immune genomics, data integration, data convergence, epigenetics, genomic instability, cancer immunology, molecular pathology, cancer transcriptomes, cell tracking, cancer evolution, immune evasion, the cancer genome, neoantigenic landscape, antitumour t-cell response, 3D analysis, translational research, cancer research, oncology

Deutsche Gesellschaft für Radioonkologie e.V. (German Society for Radiation Oncology)

At the annual congress of the German Society of Radiation Oncology (DEGRO), all those working in radiation oncology have the opportunity to discuss all aspects important for the development of radiation oncology in a concentrated form and thus come to a broad exchange of knowledge.

Kongressorganisation;     Phone: [+49 3643 2468-126];     Email: degro-registrierung@KUKM.DE

radiooncology, radiotherapy, nuclear medicine, oncology, radiology, radiation, hematology, medicine, nuclear physicians, medical technologist for radiology

Radiology, Nuclear Medicine and Radiation Therapy,    Hematology

FomF GmbH - Forum für medizinische Fortbildung

Zertifizierte Fortbildung für ÄrztInnen der Hämatologie und Onkologie vor Ort in Hamburg & via Livestream, 21.-22.06.2024. Updates & die neuesten Leitlinien. 16 CME-Punkte wurden bei der zuständigen Ärztekammer angefragt. Jetzt informieren & buchen!

Phone: [+49 (0) 6192 47072 00];     Email: info@fomf.de

Continuing Medical Education (CME),    Hematology

European Society for Medical Oncology (ESMO)

Brought to you by the European Society for Medical Oncology (ESMO), the congress will be the place to present very impactful new data in GI oncology. The scientific sessions will be complemented with high quality educational sessions and excellent networking opportunities.

In recent years we have seen remarkable progress in the treatment options available for patients with GI cancers and ESMO is committed to ensuring that there is a clear roadmap to help facilitate the implementation of new practice changing discoveries in the clinic for the benefit of all patients with GI cancers and whose wellbeing is our primary concern. The ESMO Gastrointestinal Cancers Congress will provide global visibility for original clinical and translational research.

Phone: [+41 (0)91 973 19 62];     Email: gicongress@esmo.org

Esophageal Cancer, Gastric Cancer, Hepatocellular Cancer, Pancreatic Cancer, Biliary Tract Cancer, Neuroendocrine Tumors, Colon Cancer, Rectal Cancer, GIST, Anal Cancer, Gastrointestinal Cancers

Gastroenterology,    Translational Medicine, Clinical Trials

Fields Institute

This workshop aims to showcase the state-of-the-art mathematical and computational models that are in use in mathematical oncology, with a particular focus on the fourteen hallmarks of cancer. New modeling challenges arise from these hallmarks. Some of the hallmarks relate to the characteristics of the cancer cells themselves (sub-cellular and cellular level), while others include more global effects such as blood circulation, the immune response, the effect and role of the microenvironment, mechanical forces, and the microbiome. Matching the biological diversity of the cancer hallmarks, is the diversity of mathematical approaches and techniques that have been used and are in use to give insight into the growth and spread of cancer – for example, continuum and discrete models; ordinary and partial differential equation models; individual-based and agent-based models; hybrid models; deterministic and stochastic approaches; analytical and computational approaches. Many of these processes act on very different spatial and temporal scales. Hence a new integrated multiscale mathematical modeling framework is needed to include new aspects and insights, such as spatial stochastic models and local and non-local partial differential equation models.

Modeling and Simulation,    Systems Biology and Computational Biology

Conventus Congressmanagement & Marketing GmbH

Conventus Congressmanagement & GmbH;     Email: conferencemarketing@conventus.de

Fields Institute

This workshop aims to take a closer look at how mathematical and computational models can help answer clinically relevant questions and enhance multimodal treatments. Currently, a wide range of modelling approaches study cancer and have a crucial role in treatment delivery from answering questions related to cancer biology and treatment efficacy to directly helping with treatment delivery. In this workshop, we would like to bring together clinicians, biomedical experts, experimentalists, and mathematicians to explore some of the relevant questions on multimodal treatment modelling, efficacy, optimization, drug resistance and clinical delivery.

Modeling and Simulation,    Systems Biology and Computational Biology

Fields Institute

This workshop explores research in methods aimed at connecting mathematical models of cancer evolution and clinical data. It focuses on ecology and evolution of cancer. Traditionally, ecology and evolution have been the most “mathematical” (and perhaps the first mathematical) areas of biology. Mathematical contributions to these fields made in the 20th century are now fundamental parts of scientific knowledge. More recently, methods of ecology and evolution have found their way into oncology, bridging traditional molecular biology and mathematics including stochastic processes, dynamical systems, and nonlinear partial differential equations. New biological challenges lead to difficult mathematical problems and beautiful solutions, which are both innovative mathematically and impactful from the point of view of public health. These will be the focus of the proposed workshop .

Modeling and Simulation,    Systems Biology and Computational Biology

Fields Institute

Immunotherapies have revolutionized treatments for several types of cancers, but have been met with clinical trial failures in others. The idea of eliciting an immune response against a tumour is old, but we are only just beginning to harness the potential of the immune system to treat both solid and liquid tumours. To improve immunotherapeutic approaches requires understanding how the immune system interacts around and within a tumour, allowing us to establish effective immunotherapeutic protocols. Mathematical modelling can help identify the mechanisms at the heart of immunotherapeutic efficacy and design successful therapeutic regimens. Close collaboration between experimentalists, clinicians, and quantitative researchers in academia and industry is required to forward models for implementation. This workshop will focus on tightening the links between researchers in different fields to fuel immunotherapy success.

Modeling and Simulation,    Systems Biology and Computational Biology